GlucoTrack, Inc.
GCTK • NASDAQ
GlucoTrack, Inc. is a medical - instruments & supplies company in the healthcare sector trading on NASDAQ, led by CEO Paul V. Goode, with a market cap of $1.0M.
CEOPaul V. Goode
Next Earnings
Upcoming earnings announcement for GlucoTrack, Inc.
Date
Wednesday, May 13, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
Earnings History
Past 8 earnings reports for GlucoTrack, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 30, 2026 | Q4 2025 | -$3.97 | — | - | — |  10-K |
| Nov 13, 2025 | Q3 2025 | -$4.64 | — | - | — | 10-Q |
| Aug 14, 2025 | Q2 2025 | -$9.62 | — | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.67 | — | - | — | 10-Q |
| Nov 14, 2024 | Q3 2024 | -$18.20 | — | - | — | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$16.40 | — | - | — | 10-Q |
| May 15, 2024 | Q1 2024 | -$12.00 | — | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$10.00 | — | - | — | 10-K |